Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Deflazacort
Strength: 30 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Jun 1990
Registration: 58655
Marketing authorisation holder: Laboratorios Menarini S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

DEFLAZACORT CINFA 30 mg COMPRIMIDOS EFGDeflazacort · 30,0 mg · comprimidoSpain

DEFLAZACORT CINFA 6 mg COMPRIMIDOS EFGDeflazacort · 6,0 mg · comprimidoSpain

DEFLAZACORT NORMON 30 mg COMPRIMIDOS EFGDeflazacort · 30 mg · comprimidoSpain

DEFLAZACORT NORMON 6 mg COMPRIMIDOS EFGDeflazacort · 6 mg · comprimidoSpain

DEFLAZACORT VIR 30 mg COMPRIMIDOS EFGDeflazacort · 30 mg · comprimidoSpain

DEFLAZACORT VIR 6 mg COMPRIMIDOS EFGDeflazacort · 6 mg · comprimidoSpain

DEZACOR 22,75 mg/ml GOTAS ORALES EN SUSPENSIONDeflazacort · 22,75 mg · gotas orales en suspensiónSpain

DEZACOR 30 mg COMPRIMIDOSDeflazacort · 30 mg · comprimidoSpain

DEZACOR 6 mg COMPRIMIDOSDeflazacort · 6 mg · comprimidoSpain

ZAMENE 22,75 mg/ml GOTAS ORALES EN SUSPENSIONDeflazacort · 22,75 mg · gotas orales en suspensiónSpain